DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,060 | -17.4% | 21,212 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $230,153 | +30.7% | 20,458 | +33.8% | 0.00% | 0.0% |
| Q1 2023 | $176,129 | +1.4% | 15,289 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $173,665 | -9.1% | 14,984 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $191,000 | +87.3% | 15,039 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $102,000 | -29.2% | 14,827 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -24.2% | 14,910 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $190,000 | -28.8% | 15,959 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $267,000 | -24.6% | 16,437 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $354,000 | +142.5% | 16,828 | +79.2% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | -16.1% | 9,389 | +13.5% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 8,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |